. Military Space News .
EPIDEMICS
WHO authorises China's CanSinoBIO Covid-19 vaccine
By Robin MILLARD
Geneva (AFP) May 19, 2022

The World Health Organization on Thursday gave the green light to Chinese manufacturer CanSinoBIO's Covid-19 vaccine -- the ninth jab to get the WHO seal of approval.

The WHO granted emergency use listing (EUL) authorisation to the single-shot Convidecia vaccine as China battles a resurgence of the virus triggered by the Omicron variant.

It is the third Chinese-made vaccine to be approved by the UN's health agency, after Sinovac and Sinopharm.

Convidecia was found to have 64 percent efficacy against symptomatic disease and 92 percent efficacy against severe Covid-19, the WHO said.

"The vaccine meets WHO standards for protection against Covid-19 and ... the benefits of the vaccine far outweigh risks," the UN health agency said in a statement.

The WHO's vaccine experts recommended it for people aged 18 and above.

Convidecia may be used as a booster dose following a completed primary series using any other EUL Covid-19 vaccine, said the WHO.

- Traditional vector method -

The jab has already been rolled out in several countries including China, Argentina, Chile, Malaysia, Mexico and Pakistan.

By the end of 2021, more than 58 million people had already been vaccinated with the jab, including nearly 14 million in China, the WHO said.

The WHO has now given EUL status to nine Covid-19 vaccines and variations thereof -- Pfizer/BioNTech, AstraZeneca, Janssen, Moderna, Sinovac, Sinopharm, Bharat Biotech, Novavax and CanSinoBIO.

Convidecia is based on a modified human adenovirus. The AstraZeneca and Janssen vaccines are also both based on viral vector technology.

The more traditional approach uses a genetically-engineered version of the common cold adenovirus as a "vector" to shuttle genetic instructions into human cells.

Convidecia "demonstrates a favourable safety profile in people across different age groups", eliciting strong immune responses with both binding and neutralising antibodies, said the WHO.

- Stamp of approval -

The EUL process studies the quality, safety and efficacy of vaccines and involves manufacturing site inspections.

The WHO says EUL approval gives countries, funders, procuring agencies and communities assurance that the vaccine has met international standards.

WHO's listing paves the way for countries to approve and import a vaccine for distribution quickly, especially those without an international-standard regulator of their own.

It also opens the door for the jabs to enter the Covax global vaccine-sharing facility, which aims to provide equitable access to doses around the world, particularly in poorer countries.

The WHO began reviewing rolling data on the CanSinoBIO vaccine in August.

Other vaccines are also on the path towards an EUL decision, with the WHO studying rolling data on another Sinopharm jab, and vaccines from France's Sanofi, China's Clover and Zhifei Longcom, and Iran's Shifa Pharmed.

The EUL process on Russia's Sputnik V jab has stalled.

Hundreds of candidate vaccines are being worked on in laboratories around the world.

The WHO is aware of 156 that have been in clinical development -- tested on humans -- and 198 that are in the pre-clinical phase.

rjm/rl

ASTRAZENECA

PFIZER

BioNTech

Novavax


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The Space Media Network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceMediaNetwork Contributor
$5 Billed Once


credit card or paypal
SpaceMediaNetwork Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
North Korea sent planes to China for Covid supplies: reports
Seoul (AFP) May 19, 2022
North Korea sent three of its largest cargo planes to China to pick up medical supplies to help with a spiralling Covid outbreak, local media reports say. Pyongyang announced its first-ever Covid cases last week and has since reported nearly two million cases of "fever" and 63 deaths as the virus tears through its unvaccinated population. State media reports do not specify how many of the cases and deaths have tested positive for Covid, but experts say the country's crumbling health system would ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
Turkey says still talking to Russia about missile deliveries

Lockheed Martin to produce 8th THAAD Battery for US Govt

Northrop Grumman to develop next-generation relay ground station for US Navy in Pacific

US approves $95 million sale of missile defense support to Taiwan

EPIDEMICS
DOD focused on hypersonic missile defense development, Admiral Says

Lockheed Martin delivers Long-Range Precision Strike Missile System on JLTVs

Russia admits striking Kyiv during UN chief's visit

Raytheon will not resume mass production of Stinger missiles until 2023

EPIDEMICS
4D composite printing can improve the wings of drones

Testing interactions between drones and traditional aircraft

Rapid adaptation of deep learning teaches drones to survive any weather

Chinese drone maker DJI suspends Russia, Ukraine business

EPIDEMICS
Blasting out Earth's location with the hope of reaching aliens is a controversial idea

Space Force to use ViaLite's wideband links for satellite backhaul services

Chinese military deeply alarmed over Starlink's dual-use capabilities

Terran Orbital delivers first bus in support of SDA's Transport Layer Tranche 0

EPIDEMICS
One dead in munitions blast at Russian military base

The Edge of Tomorrow aims to equip the infantry soldiers of the future

New Air Force priority topics unveiled for industry partners

Bolsonaro downplays Brazil army's Viagra order

EPIDEMICS
Prague to get German tanks in exchange for Ukraine aid

France to step up arms supplies to Ukraine, Macron tells Zelensky

Experts warn arms for Ukraine could end up in wrong hands

EU hikes military aid for Ukraine as NATO expansion faces roadblocks

EPIDEMICS
Hong Kong cardinal's arrest spotlights secretive Vatican-China deal

China slams US Asia strategy as Biden visits S.Korea, Japan

Finland, Sweden hand in applications to join NATO

Japan urges China to play 'responsible' role on Ukraine crisis

EPIDEMICS
New silicon nanowires can really take the heat

Cooling speeds up electrons in bacterial nanowires

Seeing more deeply into nanomaterials

Atom by atom: building precise smaller nanoparticles with templates









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.